SPC466

Fezolinetant

  • Status:
    Veitt
  • Application date:
    30.4.2024
  • Application published:
    15.5.2024
  • Grant published:
    15.11.2025
  • Max expiry date:
    11.12.2038
  • Medicine name:
    VEOZA
  • Medicine for children:
    No

Timeline

Today
30.4.2024Application
15.5.2024Publication
15.11.2025Registration
11.12.2038Expires

Marketing license

  • IS authorization number:
    EU/1/23/1771
  • Date:
    18.12.2023
  • Foreign authorization number:
    EU/1/23/1771
  • Date:
    7.12.2023

Owner

  • Name:
    OGEDA NV
  • Address:
    Medialaan 50, Vilvoorde 1800 BE

Agent

  • Name:
    G.H. Sigurgeirsson ehf.
  • Address:
    Borgartúni 26, 105 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 22.11.2025

Upload documents